(HealthDay News) — Despite smaller, prior studies suggesting that pioglitazone might raise users’ risk of bladder cancer, a large new study finds no statistically significant association. The research ...

Nevada case involves allegations that women developed cancer as a result of Actos medication. National network of attorneys is offering no-cost consultations to consumers seeking compensation over ...

LAFAYETTE, La., April 8, 2014 /PRNewswire/ -- A Louisiana jury has awarded $9 billion to a New York man and his wife following a trial over the man's claims that his bladder cancer was caused by the ...

Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically ...

OBJECTIVE To determine whether pioglitazone compared with other antidiabetic drugs is associated with an increased risk of bladder cancer in people with type 2 diabetes. DESIGN Population based cohort ...

W. Mark Lanier said close to 3,000 plaintiffs are in the MDL. He said hundreds of them are from Texas. When Houston's W. Mark Lanier won a verdict in a pharmaceutical case that includes $9 billion in ...

Cancer Monthly is reporting on new research published by PLoS One suggesting that the diabetes drug Actos, which is already associated with an increased risk of bladder cancer, may also increase the ...

Appellate Court upholds decision in first-ever non-settlement national RICO class action lawsuit certified against a major pharmaceutical company, with potential damages exceeding $7 billion. The ...

Actos pioglitazone is a once-daily mere medication for people with adverse 2 diabetes. As specified above, Actos has been linked to a significantly cost of actos excretion of bladder cancer in some ...

NEW YORK (Reuters Health) - A review of official reports of bad drug reactions is revealing more signs that people taking the diabetes drug Actos are at higher risk of developing bladder cancer.